首页 | 本学科首页   官方微博 | 高级检索  
     

新型抗肿瘤药物的临床应用及研究进展
引用本文:杨华,黄文荣,于力. 新型抗肿瘤药物的临床应用及研究进展[J]. 中国新药杂志, 2010, 0(6)
作者姓名:杨华  黄文荣  于力
作者单位:中国人民解放军总医院血液科;
摘    要:恶性肿瘤是当今世界严重威胁人类生命健康的常见疾病之一。其发病率逐年增加。随着新型抗肿瘤药物包括分子靶向药物(蛋白酪氨酸激酶抑制剂、肿瘤新生血管生成抑制剂)、新型内分泌治疗药物、新型化疗药物及基因治疗药物等研发,出现更多治疗恶性肿瘤新的有效方法,文中针对新型抗肿瘤药物的临床应用及研究进展进行综述。

关 键 词:分子靶向药物  内分泌治疗药物  基因治疗  肿瘤化疗  

Clinical application and research process of novel antitumor drug
YANG Hua,HUANG Wen-rong,YU Li. Clinical application and research process of novel antitumor drug[J]. Chinese Journal of New Drugs, 2010, 0(6)
Authors:YANG Hua  HUANG Wen-rong  YU Li
Affiliation:YANG Hua,HUANG Wen-rong,YU Li(Department of Haematology,Chinese PLA General Hospital,Beijing 100853,China)
Abstract:Nowadays,malignant tumor was one of the most common disease that threatened mankind life and health.Morbidity was increased year by year.The novel antitumor drugs included molecule targeted drug,protein tyrosinase inhibitor,tumor new vessels angiogenesis inhibitor,neotype chemotherapeutics,neotype endocrine medicine and gene therapy so on.More and more novel and effective treatment methods appeared.This paper introduced clinical application and progress of research of novel antitumor drug.
Keywords:molecule targeted drug  endocrine medicine  gene therapy  cancer chemotherapy  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号